Polyrizon Ltd. (NASDAQ:PLRZ) Sees Significant Growth in Short Interest

Polyrizon Ltd. (NASDAQ:PLRZ) saw a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 94,216 shares, an increase of 48.8% from the July 30th total of 63,322 shares. Based on an average daily volume of 59,143 shares, the days-to-cover ratio is currently 1.6 days. Currently, 4.5% of the shares of the stock are sold short.

Analysts Set New Price Targets

A number of brokerages have recently commented on PLRZ. Wall Street Zen upgraded shares of Polyrizon from a “sell” rating to a “hold” rating in a research report on Sunday, June 7th. Weiss Ratings upgraded shares of Polyrizon from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Polyrizon currently has an average rating of “Sell”.

Institutional Trading of Polyrizon

A hedge fund recently bought a new stake in Polyrizon stock. Jane Street Group LLC acquired a new position in shares of Polyrizon Ltd. (NASDAQ:PLRZ) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned about 1.35% of Polyrizon at the end of the most recent quarter.

Polyrizon Price Performance

Shares of PLRZ stock traded down $0.60 during trading hours on Tuesday, reaching $13.91. The company had a trading volume of 162,713 shares, compared to its average volume of 63,364. Polyrizon has a 12-month low of $2.88 and a 12-month high of $18.20. The stock has a fifty day moving average of $12.38 and a 200-day moving average of $13.11.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.